The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival, safety, and response patterns in a phase 1b multicenter trial of talimogene laherparepvec (T-VEC) and ipilimumab (ipi) in previously untreated, unresected stage IIIB-IV melanoma.
 
Igor Puzanov
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen
 
Mohammed M. Milhem
Consulting or Advisory Role - Amgen
 
Robert Hans Ingemar Andtbacka
Consulting or Advisory Role - Amgen
Speakers' Bureau - Novartis
Research Funding - Amgen; Viralytics
 
David R. Minor
Stock and Other Ownership Interests - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline
 
Omid Hamid
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Amgen; Bristol-Myers Squibb
 
Ai Li
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Jeffrey Chou
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Howard Kaufman
Consulting or Advisory Role - Alkermes; Amgen; Merck; Merck Serono; Prometheus
Research Funding - Bristol-Myers Squibb/Medarex